Drug Type Therapeutic vaccine, Genetically engineered subunit vaccine |
Synonyms HER-2 Protein AutoVac, PX 104.1, PX 1041 |
Target |
Action inhibitors, stimulants |
Mechanism EGF inhibitors(Epidermal growth factor inhibitors), Immunostimulants |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Phase 2 | Hungary | - | - |
Breast Cancer | Phase 2 | Poland | - | - |
Breast Cancer | Phase 2 | Romania | - | - |
Breast Cancer | Phase 2 | Russia | - | - |
Breast Cancer | Phase 2 | - | - |